Nigeria-eligible winger Bukayo Saka has received the medical green light ahead of Arsenal's Europa League matchday two fixture against Irish side Dundalk.
The one-cap England international had been rated doubtful for the game after playing through the pain barrier during the Gunners 1-0 defeat to Leicester City on Sunday and had to be substituted in the 65th minute.
Arsenal have issued a medical bulletin ahead of tomorrow's game and Saka is not among the players receiving treatment, paving the way for him to make his ninth appearance of the season across all competitions.
The Hale End Academy product took part in Arsenal's final training session at London Colney on Wednesday morning without any issues.
When asked at the pre-match press conference if Saka was available for selection, manager Mikel Arteta answered:"Bukayo picked up a knock but he's been training fine".
If Saka takes to the pitch against the Irish opponents at the Emirates Stadium, it would be his tenth game in the Europa League since he made his professional debut against Vorskla on November 29, 2018.
Arsenal's other opponents in Group B of the Europa League are Molde and Rapid Vienna.
Igho Kingsley
Photo Credit : arsenal.com
Copyright ANS
All rights reserved. This material, and
other digital content on this website, may not be reproduced,
published, rewritten or redistributed in whole or in part without prior
express written permission from allnigeriasoccer.com
Retired Nigeria international Yakubu Aiyegbeni has questioned manager Eric Chelle over his decision to include Tanzanian-based goalkeeper Amas Obasogie in his squad...
Turkish journalist Ali Naci Kucuk has provided fresh details on Victor Osimhen's injury situation and his strong desire to feature in the highly anticipated Fenerbahçe–Galatasaray derby. Speak...
Former Super Eagles captain John Obi Mikel has criticised Alex Iwobi for sharing a controversial video showing the state of the team’s hotel in Morocco ahead of Nigeria’s crucial 2026 FIFA World C...
Comments 0
Leave a Comment
No comments yet. Be the first to comment!